Market Analysis and Insights: Global Non-Invasive Prenatal Testing Market
The global Non-Invasive Prenatal Testing market size in 2023 is 5717.1 million US dollars, and it is expected to be 12717.9 million US dollars by 2030, with a compound annual growth rate of 12.1% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Non-Invasive Prenatal Testing market include Genesis Genetics (CooperSurgical, Inc.), Natera, Inc., Centogene N.V., Illumina, Inc. (Verinata Health, Inc.), and Eurofins LifeCodexx GmbH. The share of the top 3 players in the Non-Invasive Prenatal Testing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Non-Invasive Prenatal Testing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Instruments accounted for XX% of Non-Invasive Prenatal Testing market in 2023. Kits and Reagents share of XX%.
Down Syndrome (trisomy 21) accounted for XX% of the Non-Invasive Prenatal Testing market in 2023. Edwards Syndrome (trisomy 18) accounts for XX%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Invasive Prenatal Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Invasive Prenatal Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Invasive Prenatal Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Invasive Prenatal Testing market.

Global Non-Invasive Prenatal Testing Scope and Market Size
Non-Invasive Prenatal Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Prenatal Testing market will be able to gain the upper hand as they use the report as a powerful resource.

The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Non-Invasive Prenatal Testing industry is considered in the report, covering the dynamic analysis of the development of the Non-Invasive Prenatal Testing industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Genesis Genetics (CooperSurgical, Inc.)
Natera, Inc.
Centogene N.V.
Illumina, Inc. (Verinata Health, Inc.)
Eurofins LifeCodexx GmbH
MedGenome Labs Ltd.
F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
Myriad Women’s Health, Inc. (Counsyl, Inc.)
Progenity, Inc.
Qiagen
Laboratory Corp. of America Holdings
Quest Diagnostics, Inc.

Types list
Instruments
Kits and Reagents
Services

Application list
Down Syndrome (trisomy 21)
Edwards Syndrome (trisomy 18)
Patau Syndrome (trisomy 13)
Turner Syndrome
Other Applications

Table of Content

1 Non-Invasive Prenatal Testing Market Introduction and Overview
1.1 Non-Invasive Prenatal Testing Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Non-Invasive Prenatal Testing Industry Dynamic Analysis
1.5.1 Non-Invasive Prenatal Testing Market Trends Analysis
1.5.2 Non-Invasive Prenatal Testing Market Drivers Analysis
1.5.3 Non-Invasive Prenatal Testing Market Challenges Analysis
1.5.4 Non-Invasive Prenatal Testing Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Non-Invasive Prenatal Testing Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Non-Invasive Prenatal Testing Revenue and Share by Type
2.3 Global Non-Invasive Prenatal Testing Sales and Share by Type
3 Global Non-Invasive Prenatal Testing Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Non-Invasive Prenatal Testing Revenue and Share by Application (2019-2024)
3.3 Global Non-Invasive Prenatal Testing Sales and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Non-Invasive Prenatal Testing Market Size (2019-2024)
4.2 Non-Invasive Prenatal Testing Growth Insights by Regions
4.2.1 Non-Invasive Prenatal Testing Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Non-Invasive Prenatal Testing Revenue Market Size by Regions (2019-2024)
4.2.3 Non-Invasive Prenatal Testing Sales Market Size by Regions (2019-2024)
4.2.4 North America Non-Invasive Prenatal Testing Market Size (2019-2024)
4.2.5 Europe Non-Invasive Prenatal Testing Market Size (2019-2024)
4.2.6 Asia-Pacific Non-Invasive Prenatal Testing Market Size (2019-2024)
4.2.7 Latin America Non-Invasive Prenatal Testing Market Size (2019-2024)
4.2.8 Middle East & Africa Non-Invasive Prenatal Testing Market Size (2019-2024)
5 North America
5.1 North America Non-Invasive Prenatal Testing Revenue by Countries
5.1.1 North America Non-Invasive Prenatal Testing Revenue by Countries (2019-2024)
5.1.2 North America Non-Invasive Prenatal Testing Sales by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Non-Invasive Prenatal Testing Revenue by Countries
6.1.1 Asia Pacific Non-Invasive Prenatal Testing Revenue by Countries (2019-2024)
6.1.2 Asia Pacific Non-Invasive Prenatal Testing Sales by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Non-Invasive Prenatal Testing Revenue by Countries
7.1.1 Europe Non-Invasive Prenatal Testing Revenue by Countries (2019-2024)
7.1.2 Europe Non-Invasive Prenatal Testing Sales by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Non-Invasive Prenatal Testing Revenue by Countries
8.1.1 Latin America Non-Invasive Prenatal Testing Revenue by Countries (2019-2024)
8.1.2 Latin America Non-Invasive Prenatal Testing Sales by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Non-Invasive Prenatal Testing Revenue by Countries
9.1.1 Middle East & Africa Non-Invasive Prenatal Testing Revenue by Countries (2019-2024)
9.1.2 Middle East & Africa Non-Invasive Prenatal Testing Sales by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Non-Invasive Prenatal Testing Market Competition, by Players
10.1 Global Non-Invasive Prenatal Testing Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Non-Invasive Prenatal Testing Players Market Share in 2023
10.2.2 Top 6 Non-Invasive Prenatal Testing Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Non-Invasive Prenatal Testing Players Head Office, Business Provided
10.4 Non-Invasive Prenatal Testing Mergers & Acquisitions
10.5 Non-Invasive Prenatal Testing New Entrants and Expansion Plans
11 Players Profiles
11.1 Genesis Genetics (CooperSurgical, Inc.)
11.1.1 Genesis Genetics (CooperSurgical, Inc.) Company Profile
11.1.2 Non-Invasive Prenatal Testing Product Overview
11.1.3 Genesis Genetics (CooperSurgical, Inc.) Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.1.4 Genesis Genetics (CooperSurgical, Inc.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Natera, Inc.
11.2.1 Natera, Inc. Company Profile
11.2.2 Non-Invasive Prenatal Testing Product Overview
11.2.3 Natera, Inc. Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.2.4 Natera, Inc. Business Overview
11.2.5 Recent Developments and Plans
11.3 Centogene N.V.
11.3.1 Centogene N.V. Company Profile
11.3.2 Non-Invasive Prenatal Testing Product Overview
11.3.3 Centogene N.V. Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.3.4 Centogene N.V. Business Overview
11.3.5 Recent Developments and Plans
11.4 Illumina, Inc. (Verinata Health, Inc.)
11.4.1 Illumina, Inc. (Verinata Health, Inc.) Company Profile
11.4.2 Non-Invasive Prenatal Testing Product Overview
11.4.3 Illumina, Inc. (Verinata Health, Inc.) Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.4.4 Illumina, Inc. (Verinata Health, Inc.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Eurofins LifeCodexx GmbH
11.5.1 Eurofins LifeCodexx GmbH Company Profile
11.5.2 Non-Invasive Prenatal Testing Product Overview
11.5.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.5.4 Eurofins LifeCodexx GmbH Business Overview
11.5.5 Recent Developments and Plans
11.6 MedGenome Labs Ltd.
11.6.1 MedGenome Labs Ltd. Company Profile
11.6.2 Non-Invasive Prenatal Testing Product Overview
11.6.3 MedGenome Labs Ltd. Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.6.4 MedGenome Labs Ltd. Business Overview
11.6.5 Recent Developments and Plans
11.7 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
11.7.1 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Company Profile
11.7.2 Non-Invasive Prenatal Testing Product Overview
11.7.3 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.7.4 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Business Overview
11.7.5 Recent Developments and Plans
11.8 Myriad Women’s Health, Inc. (Counsyl, Inc.)
11.8.1 Myriad Women’s Health, Inc. (Counsyl, Inc.) Company Profile
11.8.2 Non-Invasive Prenatal Testing Product Overview
11.8.3 Myriad Women’s Health, Inc. (Counsyl, Inc.) Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.8.4 Myriad Women’s Health, Inc. (Counsyl, Inc.) Business Overview
11.8.5 Recent Developments and Plans
11.9 Progenity, Inc.
11.9.1 Progenity, Inc. Company Profile
11.9.2 Non-Invasive Prenatal Testing Product Overview
11.9.3 Progenity, Inc. Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.9.4 Progenity, Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Qiagen
11.10.1 Qiagen Company Profile
11.10.2 Non-Invasive Prenatal Testing Product Overview
11.10.3 Qiagen Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.10.4 Qiagen Business Overview
11.10.5 Recent Developments and Plans
11.11 Laboratory Corp. of America Holdings
11.11.1 Laboratory Corp. of America Holdings Company Profile
11.11.2 Non-Invasive Prenatal Testing Product Overview
11.11.3 Laboratory Corp. of America Holdings Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.11.4 Laboratory Corp. of America Holdings Business Overview
11.11.5 Recent Developments and Plans
11.12 Quest Diagnostics, Inc.
11.12.1 Quest Diagnostics, Inc. Company Profile
11.12.2 Non-Invasive Prenatal Testing Product Overview
11.12.3 Quest Diagnostics, Inc. Non-Invasive Prenatal Testing Market Performance (2019-2024)
11.12.4 Quest Diagnostics, Inc. Business Overview
11.12.5 Recent Developments and Plans
12 Non-Invasive Prenatal Testing Manufacturing Cost Analysis
12.1 Non-Invasive Prenatal Testing Key Raw Materials Analysis
12.1.1 Key Raw Materials
12.1.2 Price Trend of Key Raw Materials
12.1.3 Key Suppliers of Raw Materials
12.2 Proportion of Manufacturing Cost Structure
12.2.1 Raw Materials
12.2.2 Labor Cost
12.2.3 Manufacturing Expenses
12.3 Manufacturing Process Analysis of Non-Invasive Prenatal Testing
12.4 Non-Invasive Prenatal Testing Industrial Chain Analysis
13 Market Channel, Distributors, Traders and Dealers
13.1 Market Channel Status
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-Invasive Prenatal Testing Typical Distributors
13.3 Non-Invasive Prenatal Testing Typical Customers
14 Global Non-Invasive Prenatal Testing Forecast Market Insights by Type
14.1 Global Non-Invasive Prenatal Testing Revenue Market Forecast by Type (2024-2030)
14.2 Global Non-Invasive Prenatal Testing Sales Market Forecast by Type (2024-2030)
15 Global Non-Invasive Prenatal Testing Forecast Market Insights by Application
15.1 Non-Invasive Prenatal Testing Revenue Market Forecast by Application (2024-2030)
15.2 Non-Invasive Prenatal Testing Sales Market Forecast by Application (2024-2030)
16 Global Market Growth Forecast Insights
16.1 Global Non-Invasive Prenatal Testing Forecast Market Size (2024-2030)
16.2 Non-Invasive Prenatal Testing Growth Forecast Insights by Regions
16.2.1 Non-Invasive Prenatal Testing Revenue Forecast Market Size by Regions (2024-2030)
16.2.2 Non-Invasive Prenatal Testing Sales Forecast Market Size by Regions (2024-2030)
16.2.3 North America Non-Invasive Prenatal Testing Forecast Market Size (2024-2030)
16.2.4 Europe Non-Invasive Prenatal Testing Forecast Market Size (2024-2030)
16.2.5 Asia-Pacific Non-Invasive Prenatal Testing Forecast Market Size (2024-2030)
16.2.6 Latin America Non-Invasive Prenatal Testing Forecast Market Size (2024-2030)
16.2.7 Middle East & Africa Non-Invasive Prenatal Testing Forecast Market Size (2024-2030)
17 Research Findings and Conclusion
18 Methodology and Data Source
18.1 A Methodology
18.1.1 Research Process
18.1.2 Market Size Estimation
18.1.3 Market Breakdown and Data Triangulation
18.2 B Data Source
18.2.1 Legal Disclaimer

List of Tables and Figures

Figure Non-Invasive Prenatal Testing Picture
Table Product Definition of Non-Invasive Prenatal Testing
Table Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Non-Invasive Prenatal Testing Production by Players (2019-2024)
Table Global Non-Invasive Prenatal Testing Production Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Non-Invasive Prenatal Testing in 2024
Figure Top 10 Largest Players of Non-Invasive Prenatal Testing in 2024
Table Global Non-Invasive Prenatal Testing Revenue by Players (2019-2024)
Table Global Non-Invasive Prenatal Testing Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Non-Invasive Prenatal Testing in 2024
Figure Top 10 Largest Players of Non-Invasive Prenatal Testing in 2024
Table Global Non-Invasive Prenatal Testing Production Price by Players
Table Players Market Concentration Ratio (CR5)
Table Global Non-Invasive Prenatal Testing Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Genesis Genetics (CooperSurgical, Inc.) Overview
Table Genesis Genetics (CooperSurgical, Inc.) Production, Price, Value, Gross, Gross Margin 2019-2024
Table Genesis Genetics (CooperSurgical, Inc.) Related Developments
Table Company Profiles
Table Natera, Inc. Overview
Table Natera, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Natera, Inc. Related Developments
Table Company Profiles
Table Centogene N.V. Overview
Table Centogene N.V. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Centogene N.V. Related Developments
Table Company Profiles
Table Illumina, Inc. (Verinata Health, Inc.) Overview
Table Illumina, Inc. (Verinata Health, Inc.) Production, Price, Value, Gross, Gross Margin 2019-2024
Table Illumina, Inc. (Verinata Health, Inc.) Related Developments
Table Company Profiles
Table Eurofins LifeCodexx GmbH Overview
Table Eurofins LifeCodexx GmbH Production, Price, Value, Gross, Gross Margin 2019-2024
Table Eurofins LifeCodexx GmbH Related Developments
Table Company Profiles
Table MedGenome Labs Ltd. Overview
Table MedGenome Labs Ltd. Production, Price, Value, Gross, Gross Margin 2019-2024
Table MedGenome Labs Ltd. Related Developments
Table Company Profiles
Table F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Overview
Table F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Production, Price, Value, Gross, Gross Margin 2019-2024
Table F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) Related Developments
Table Company Profiles
Table Myriad Women’s Health, Inc. (Counsyl, Inc.) Overview
Table Myriad Women’s Health, Inc. (Counsyl, Inc.) Production, Price, Value, Gross, Gross Margin 2019-2024
Table Myriad Women’s Health, Inc. (Counsyl, Inc.) Related Developments
Table Company Profiles
Table Progenity, Inc. Overview
Table Progenity, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Progenity, Inc. Related Developments
Table Company Profiles
Table Qiagen Overview
Table Qiagen Production, Price, Value, Gross, Gross Margin 2019-2024
Table Qiagen Related Developments
Table Company Profiles
Table Laboratory Corp. of America Holdings Overview
Table Laboratory Corp. of America Holdings Production, Price, Value, Gross, Gross Margin 2019-2024
Table Laboratory Corp. of America Holdings Related Developments
Table Company Profiles
Table Quest Diagnostics, Inc. Overview
Table Quest Diagnostics, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Quest Diagnostics, Inc. Related Developments
Table Global Non-Invasive Prenatal Testing Production by Type (2019-2024)
Table Global Non-Invasive Prenatal Testing Production Share by Type (2019-2024)
Table Global Non-Invasive Prenatal Testing Forecasted Production by Type (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Production Share by Type (2024-2030)
Table Global Non-Invasive Prenatal Testing Value by Type (2019-2024)
Table Global Non-Invasive Prenatal Testing Value Share by Type (2019-2024)
Table Global Non-Invasive Prenatal Testing Forecasted Value by Type (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Value Share by Type (2024-2030)
Table Global Non-Invasive Prenatal Testing Price by Type (2019-2024)
Table Global Non-Invasive Prenatal Testing Price Forecast by Type (2024-2030)
Table Global Non-Invasive Prenatal Testing Consumption by Application (2019-2024)
Table Global Non-Invasive Prenatal Testing Consumption Share by Application (2019-2024)
Table Global Non-Invasive Prenatal Testing Forecasted Consumption by Application (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Consumption Share by Application (2024-2030)
Table Global Non-Invasive Prenatal Testing Revenue by Application (2019-2024)
Table Global Non-Invasive Prenatal Testing Revenue Share by Application (2019-2024)
Table Global Non-Invasive Prenatal Testing Forecasted Revenue by Application (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Revenue Share by Application (2024-2030)
Table Global Non-Invasive Prenatal Testing Price by Application (2019-2024)
Table Global Non-Invasive Prenatal Testing Price Forecast by Application (2024-2030)
Figure Global Non-Invasive Prenatal Testing Production (2019-2030)
Figure Global Non-Invasive Prenatal Testing Value (2019-2030)
Table Global Non-Invasive Prenatal Testing Production by Region: 2019 VS 2024 VS 2030
Table Global Non-Invasive Prenatal Testing Historic Production by Region (2019-2024)
Table Global Non-Invasive Prenatal Testing Historic Production Share by Region (2019-2024)
Table Global Non-Invasive Prenatal Testing Historic Value by Region (2019-2024)
Table Global Non-Invasive Prenatal Testing Historic Value Share by Region (2019-2024)
Table Global Non-Invasive Prenatal Testing Forecasted Production by Region (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Production Share by Region (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Value by Region (2024-2030)
Table Global Non-Invasive Prenatal Testing Forecasted Value Share by Region (2024-2030)
Figure North America Non-Invasive Prenatal Testing Production (2019-2030)
Figure North America Non-Invasive Prenatal Testing Value (2019-2030)
Table North America Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Europe Non-Invasive Prenatal Testing Production (2019-2030)
Figure Europe Non-Invasive Prenatal Testing Value (2019-2030)
Table Europe Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure China Non-Invasive Prenatal Testing Production (2019-2030)
Figure China Non-Invasive Prenatal Testing Value (2019-2030)
Table China Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Japan Non-Invasive Prenatal Testing Production (2019-2030)
Figure Japan Non-Invasive Prenatal Testing Value (2019-2030)
Table Japan Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Global Non-Invasive Prenatal Testing Sales Estimates and Forecasts 2019-2030
Table Global Non-Invasive Prenatal Testing Sales by Region: 2019 VS 2024 VS 2030
Table Global Non-Invasive Prenatal Testing Sales by Region (2019-2024)
Table Global Non-Invasive Prenatal Testing Sales Share by Region (2019-2024)
Table Global Non-Invasive Prenatal Testing Sales by Region (2024-2030)
Table Global Non-Invasive Prenatal Testing Sales Share by Region (2024-2030)
Figure North America Non-Invasive Prenatal Testing Sales (2019-2030)
Table North America Non-Invasive Prenatal Testing Sales by Country (2019-2030)
Table North America Non-Invasive Prenatal Testing Sales Share by Country (2019-2030)
Figure United States Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Canada Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Europe Non-Invasive Prenatal Testing Sales (2019-2030)
Table Europe Non-Invasive Prenatal Testing Sales by Country (2019-2030)
Table Europe Non-Invasive Prenatal Testing Sales Share by Country (2019-2030)
Figure Germany Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure France Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure U.K. Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Italy Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Russia Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Asia-Pacific Non-Invasive Prenatal Testing Sales (2019-2030)
Table Asia Pacific Non-Invasive Prenatal Testing Sales by Region (2019-2030)
Table Asia Pacific Non-Invasive Prenatal Testing Sales Share by Region (2019-2030)
Figure China Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Japan Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure South Korea Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure India Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Southeast Asia Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Australia Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Latin America Non-Invasive Prenatal Testing Sales (2019-2030)
Table Latin America Non-Invasive Prenatal Testing Sales by Country (2019-2030)
Table Latin America Non-Invasive Prenatal Testing Sales Share by Country (2019-2030)
Figure Mexico Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Brazil Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Middle East & Africa Non-Invasive Prenatal Testing Sales (2019-2030)
Table Middle East and Africa Non-Invasive Prenatal Testing Sales by Country (2019-2030)
Table Middle East and Africa Non-Invasive Prenatal Testing Sales Share by Country (2019-2030)
Figure Turkey Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure Saudi Arabia Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Figure U.A.E Non-Invasive Prenatal Testing Sales Market Size (2019-2030)
Table Raw Material
Table Raw Materials Key Suppliers
Figure Sales Channels
Table Major Distributors of Non-Invasive Prenatal Testing with Contact Information
Table Major Customers of Non-Invasive Prenatal Testing with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report